Glioblastoma cells use mitochondria from the central nervous system to grow and form more aggressive tumors, a new study finds. The finding suggests new opportunities for therapeutic development.Read More
Switching Disease-Modifying Therapies in Pediatric Multiple Sclerosis: Insights From Real-World Data
For young patients on platform injectable disease-modifying therapy (DMT), switching to an oral or infusion DMT was associated with lower relapse rates compared with switching to another injectable DMT.
Shorter Ocrelizumab Infusion Time for Multiple Sclerosis Does Not Affect Safety Profile
Reducing the biologic agent’s infusion time to just two hours was associated with similar frequency and severity of infusion-related reactions compared with conventional 3.5-hour infusion in a substudy of ENSEMBLE PLUS.
Management of Lung Cancer Brain Metastases: An Update
Treatment goals in this setting are to extend survival, prevent neurological dysfunction and improve quality of life. Advances is surgical safety, stereotactic radiosurgery and systemic therapies have yielded mounting progress.
Neighborhood Deprivation Linked to Adverse Neuropsychological Effects in Temporal Lobe Epilepsy
People with TLE are more likely to have deficits in cognitive function and depressed mood if they live in neighborhoods that are disadvantaged, a registry-based study finds.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Clinical Trials for Brain and Spine Tumors: Challenges and Opportunities (Podcast)
A neuro-oncologist and researcher discusses growing efforts to translate genetic discoveries into personalized therapeutic options as well as the importance of collaboration, advocacy and trial funding.
Markers of Metabolic Syndrome Linked to Cognitive Decline in MCI and Alzheimer’s
Elevations in plasma triglyceride/HDL cholesterol ratio and plasma apolipoprotein A1 were associated with worse cognitive outcomes in a retrospective study of people with mild cognitive impairment or Alzheimer’s disease dementia.
Understanding the Risk Factors for Postoperative ED Visits Following Endoscopic Skull Base Surgery
New research suggests ways to improve patient outcomes and prevent unnecessary ED visits following endoscopic skull base surgery.
Renewed Interest in Psychedelic Treatment for Behavioral Health Conditions (Podcast)
Our latest Neuro Pathways podcast explores the current state of research on psychedelics for depression, anxiety, PTSD and more, along with safety concerns and abuse risk.
Can Artificial Intelligence Point the Way to Better Spine Care?
Cleveland Clinic will soon implement an AI platform to guide clinical decision-making around spine surgery. Three of the platform’s architects explain its origins, capabilities and potential impact.
6 Things to Know About the Future Home of Our Neurological Institute
We’re building a new hub for neurological care on our main campus equipped with ideal spaces and technologies for delivering the best care possible today while developing the care of tomorrow.